Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry.
Hanjin ParkHee Tae YuTae-Hoon KimJunbeom ParkJin-Kyu ParkKi Woon KangJaemin ShimJin-Bae KimJun KimEue-Keun ChoiHyung-Wook ParkYoung Soo LeeBoyoung JoungPublished in: Yonsei medical journal (2022)
Among AF patients with advanced CKD or ESRD on dialysis, DOAC was associated with a lower risk of major or CRNM bleeding compared to warfarin and a lower risk of composite adverse clinical outcomes compared to no OAC. ClinicalTrials.gov (NCT02786095).
Keyphrases
- atrial fibrillation
- chronic kidney disease
- end stage renal disease
- direct oral anticoagulants
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- heart failure
- peritoneal dialysis
- percutaneous coronary intervention
- stem cells
- emergency department
- venous thromboembolism
- bone marrow
- left ventricular
- electronic health record